Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Topical liquiritin improves melasma.

Amer M, Metwalli M.

Int J Dermatol. 2000 Apr;39(4):299-301.

PMID:
10809983
2.

Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.

Khemis A, Kaiafa A, Queille-Roussel C, Duteil L, Ortonne JP.

Br J Dermatol. 2007 May;156(5):997-1004. Epub 2007 Mar 28.

PMID:
17388924
3.

Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial.

Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ.

Br J Dermatol. 1993 Oct;129(4):415-21.

PMID:
8217756
4.

Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial.

Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ.

Arch Dermatol. 1994 Jun;130(6):727-33.

PMID:
8002642
5.

The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream.

Baliña LM, Graupe K.

Int J Dermatol. 1991 Dec;30(12):893-5.

PMID:
1816137
6.

Topical 10% zinc sulfate solution for treatment of melasma.

Sharquie KE, Al-Mashhadani SA, Salman HA.

Dermatol Surg. 2008 Oct;34(10):1346-9. doi: 10.1111/j.1524-4725.2008.34287.x. Epub 2008 Jun 27.

PMID:
18616534
7.

Skin-lightening effects of a new face care product in patients with melasma.

Scherdin U, Bürger A, Bielfeldt S, Filbry A, Weber T, Schölermann A, Wigger-Alberti W, Rippke F, Wilhelm KP.

J Cosmet Dermatol. 2008 Mar;7(1):68-75. doi: 10.1111/j.1473-2165.2008.00364.x.

PMID:
18254815
8.

Topical isotretinoin for melasma in Thai patients: a vehicle-controlled clinical trial.

Leenutaphong V, Nettakul A, Rattanasuwon P.

J Med Assoc Thai. 1999 Sep;82(9):868-75.

PMID:
10561942
9.

Efficacy of dioic acid compared with hydroquinone in the treatment of melasma.

Tirado-Sánchez A, Santamaría-Román A, Ponce-Olivera RM.

Int J Dermatol. 2009 Aug;48(8):893-5. doi: 10.1111/j.1365-4632.2009.04105.x.

PMID:
19659872
10.

Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial.

Huh SY, Shin JW, Na JI, Huh CH, Youn SW, Park KC.

J Dermatol. 2010 Apr;37(4):311-5. doi: 10.1111/j.1346-8138.2010.00787.x.

PMID:
20507399
11.

Lactic acid as a new therapeutic peeling agent in melasma.

Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA.

Dermatol Surg. 2005 Feb;31(2):149-54; discussion 154.

PMID:
15762205
12.

Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.

Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, Park YM.

Dermatol Surg. 2006 May;32(5):626-31.

PMID:
16706756
13.

Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels.

Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA.

Dermatol Surg. 2006 Dec;32(12):1429-36.

PMID:
17199649
14.
15.

Utilizing fractional resurfacing in the treatment of therapy-resistant melasma.

Tannous ZS, Astner S.

J Cosmet Laser Ther. 2005 Mar;7(1):39-43.

PMID:
16020216
16.

Treatment of refractory melasma with combination of topical 5% magnesium ascorbyl phosphate and fluorescent pulsed light in Asian patients.

Shaikh ZI, Mashood AA.

Int J Dermatol. 2014 Jan;53(1):93-9. doi: 10.1111/ijd.12195. Epub 2013 Oct 29.

PMID:
24168559
17.

[Facial melanosis (melasma)].

Witkiewicz IM, Neering H.

Ned Tijdschr Geneeskd. 1981 Apr 18;125(16):609-11. Dutch.

PMID:
7242709
18.

The treatment of melasma by silymarin cream.

Altaei T.

BMC Dermatol. 2012 Oct 2;12:18. doi: 10.1186/1471-5945-12-18.

20.

Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.

Grimes PE, Bhawan J, Guevara IL, Colón LE, Johnson LA, Gottschalk RW, Pandya AG.

J Am Acad Dermatol. 2010 Jun;62(6):962-7. doi: 10.1016/j.jaad.2009.06.067. Epub 2010 Apr 15.

PMID:
20398959

Supplemental Content

Support Center